Whalesbook
Achanak stock mein itni badi girawat kyu?
Asal mein, 14 May 2026 ko Sharda Cropchem ke shares mein lagbhag 12% ki girawat aayi aur stock ₹1,043.8 ke all-time low par aa gaya. Ye sab tab hua jab company ne Q4 FY26 ke results announce kiye, jisme profit aur revenue dono mein zabardast growth dikhi. Stock ka girna Nifty50 index ke 1.45% badhne ke bavajood hua, jo ye batata hai ki investors sirf results se zyada kuch aur soch rahe hain.
Q4 Mein Toh Sab Kuch Badhiya Tha
Company ne Q4 FY26 mein Profit After Tax (PAT) mein 57% ka zabardast jump dikhaya, jo ₹204 crore se badh kar ₹319 crore ho gaya. Revenue bhi 13% badh kar ₹1,829 crore se ₹2,065 crore pahunch gaya. Ye growth agrochemical volumes mein 4.3% ki badhotri aur Europe aur Latin America mein achhi performance se aayi. EBITDA toh 75% badh kar ₹513 crore ho gaya aur margins bhi 24.8% tak pahunch gaye. Poore FY26 ke liye, revenue 22% badh kar ₹5,268 crore raha aur PAT 124% badh kar ₹681 crore ho gaya. ROCE bhi record 30.4% raha. Company ne final dividend ₹9 per share bhi propose kiya hai, jisse FY26 ka total ₹15 ho gaya.
Toh Problem Kahan Hai?
Itne acche financials aur zero debt hone ke bawajood stock ka girna investors ke valuation ya future growth ko lekar chintit hone ka ishara hai. Sharda Cropchem ka trailing P/E ratio 15x-21x hai, jo PI Industries (33.48x), Bayer CropScience (29.86x), aur UPL (28.31x) jaise competitors se kam hai. EV/EBITDA bhi 9.57x hai, matlab stock competitively valued hai. Lekin shayad market ko isse bhi zyada growth ki ummeed thi jo current results puri tarah se satisfy nahi kar paaye, khas kar sector ke overall problems ko dekhte hue.
Sector Mein Challenges Badi Hain
Indian agrochemical sector FY27 mein 6-8% grow hone ki ummeed hai, par isse kai challenges face karne pad rahe hain. China se intense competition aur global oversupply prices par pressure bana rahe hain. Geopolitical issues ki wajah se energy aur logistics costs volatile hain. China dwara key materials par VAT export rebates hatane se Indian companies ke liye cost pressure badh gaya hai. Ye sab badi issues lagta hai investors ke mood ko zyada affect kar rahe hain Sharda ke specific performance se.
Sustainability Aur Competition Ka Risk
Stock ka itna zyada girna, acche margins aur ROCE ke bavajood, ye dikhata hai ki investors ko doubt hai ki ye sab maintain ho payega ya nahi. Management FY27 ke liye stable margins ka forecast kar raha hai, par competition aur input costs ka risk bana hua hai. Sharda Cropchem ke key export markets jaise Europe aur Latin America mein slowdown ya new regulations aa sakti hain. China ke VAT export rebate hatane se Indian companies ka cost advantage kam ho sakta hai agar woh higher prices pass on nahi kar paayein.
Analysts Kya Keh Rahe Hain?
Analysts generally positive hain, consensus 'Buy' rating de rahe hain aur average 12-month price targets ₹1,260.50 se ₹1,288.26 ke beech hain, jo potential upside dikhate hain. Lekin, stock ka recent fall bata raha hai ki market in future estimates ko current economic aur competition challenges ke khilaaf weigh kar raha hai. Management confident hai, registration pipeline aur growing market presence ki taraf ishara kar raha hai. Sharda Cropchem ka global supply chain issues ko manage karna, volatile input costs ko control karna, aur pricing power maintain rakhna hi investors ka trust wapas jeetne ke liye important hoga.